A study shows gut bacteria can reprogram fat to burn energy, offering new targets for obesity and metabolic disease.
In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as pivotal players, offering new avenues for understanding the fine-tuned ...
Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities. Heterogeneity and drug resistance among tumors pose a serious challenge ...
The first-in-class injectable could be the next big thing in diabetes and obesity treatment.